Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor
Authors:
- Jian-Hua YouJYJian-Hua You
- Wen WuWWWen Wu
- Jun-Min LiJLJun-Min Li
- Zhi-Xiang ShenZSZhi-Xiang Shen
- Ai-Hua WangAWAi-Hua Wang
- 1 October 2013
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 37 (10) , 1216-1221
Abstract
No abstract availableKeywords
Funding Information
- Terry Fox Foundation
This publication has 21 references indexed in Scilit:
- Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse modelLeukemia Research, 2012
- Fatherhood during imatinibActa Oncologica, 2011
- Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006Journal of Experimental & Clinical Cancer Research, 2010
- Platelet-Derived Growth Factor Receptor β-Subtype Regulates Proliferation and Migration of GonocytesEndocrinology, 2008
- Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testisReproductive Toxicology, 2008
- Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: Report of five casesLeukemia Research, 2008
- Inhibition of tyrosine kinases PDGFR and C‐Kit by imatinib mesylate interferes with postnatal testicular development in the ratInternational Journal of Andrology, 2007
- Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapyBritish Journal of Haematology, 2007
- Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With ImatinibJournal of Clinical Oncology, 2006
- Imatinib treatment: Specific issues related to safety, fertility, and pregnancySeminars in Hematology, 2003